tiprankstipranks
Hemostemix Inc (TSE:HEM)
:HEM
Canadian Market
Holding TSE:HEM?
Track your performance easily

Hemostemix (HEM) Financial Statements

15 Followers

Hemostemix Financial Overview

Hemostemix's market cap is currently ―. The company's EPS TTM is C$-0.023; its P/E ratio is ―; Hemostemix is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -157.17K$ -368.82K$ -329.98K$ -455.16K$ -142.02K
EBITDA$ -157.15K$ -368.79K$ -329.95K$ -455.11K$ -141.97K
Net Income Common Stockholders$ -314.56K$ -519.35K$ -475.53K$ -683.59K$ -257.24K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 63.33K$ 103.75K$ 35.07K$ 155.42K$ 377.59K
Total Assets$ 158.31K$ 243.78K$ 94.36K$ 313.76K$ 701.15K
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 8.83M$ 8.60M$ 7.94M$ 7.68M$ 7.55M
Stockholders Equity$ -8.67M$ -8.36M$ -7.84M$ -7.37M$ -6.85M
Cash Flow-
Free Cash Flow--$ -120.35K$ -240.49K$ -66.14K
Operating Cash Flow--$ -120.35K$ -240.49K$ -66.14K
Investing Cash Flow-----
Financing Cash Flow---$ 18.31K$ 289.41K
Currency in USD

Hemostemix Earnings and Revenue History

Hemostemix Debt to Assets

Hemostemix Cash Flow

Hemostemix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis